Skip to main navigation Skip to search Skip to main content

EF-32 (TRIDENT): A pivotal randomized, open-label study of Optune (TTfields, 200 KHZ) concomitant with radiation therapy and temozolomide for the treatment of newly diagnosed glioblastoma

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

Klinische Prüfung eines Medizinproduktes mit CE-Kennzeichnung
Short titleTRIDENT/EF-21
StatusFinished
Effective start/end date28.10.2021 → 19.05.2026

Fields of science

  • 302052 Neurology
  • 302058 Palliative medicine
  • 302055 Oncology
  • 302030 Internal medicine